Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  De Lisle, Robert C ^a   Mueller, Racquel ^a   Roach, Eileen ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; BIOLOGICAL MARKER; CHLORIDE CHANNEL; LUBIPROSTONE; MAST CELL PROTEASE 2; RHODAMINE; RNA 16S; SERINE PROTEINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PROSTAGLANDIN E1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CONTROLLED STUDY; CRYPT CELL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; INNATE IMMUNITY; INTESTINE TRANSIT TIME; LITTER SIZE; MALE; MICROARRAY ANALYSIS; MORPHOLOGICAL TRAIT; MOUSE; MUCUS SECRETION; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PHENOTYPE; QUANTITATIVE ANALYSIS; SMALL INTESTINE DISEASE; STOMACH EMPTYING; STOMACH PROTECTION; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; TISSUE STRUCTURE; WEIGHT GAIN; WILD TYPE; ANIMAL; BACTERIAL LOAD; BACTERIUM; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; SMALL INTESTINE;

ALPROSTADIL; ANIMALS; BACTERIA; BACTERIAL LOAD; CHLORIDE CHANNELS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTESTINE, SMALL; MICE; MICE, INBRED C57BL; PHENOTYPE;

EID: 77956541119     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-107     Document Type: Article

References (40)

1. Robert R, Carlile GW, Pavel C, Liu N, Anjos SM, Liao J, Luo Y, Zhang D, Thomas DY, Hanrahan JW. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. Mol Pharmacol 2008, 73:478-489. PMID:17975008, 10.1124/mol.107.040725, 17975008.
2. Macdonald KD, McKenzie KR, Henderson MJ, Hawkins CE, Vij N, Zeitlin PL. Lubiprostone activates non-CFTR dependent respiratory epithelial chloride secretion in cystic fibrosis mice. Am J Physiol Lung Cell Mol Physiol 2008, PMID:18805957, 2584880, 18805957.
3. Hirche TO, Hirche H, Jungblut S, Stern M, Wagner TO, Wiedemann B. Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis. J Cyst Fibros 2009, 8:238-244. PMID:19419910, 10.1016/j.jcf.2009.03.004, 19419910.
4. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004, 72:6040-6049. PMID:15385508, 10.1128/IAI.72.10.6040-6049.2004, 517588, 15385508.
5. De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 2006, 42:46-52. PMID:16385253, 10.1097/01.mpg.0000189322.34582.3e, 16385253.
6. Jeffrey I, Durrans D, Wells M, Fox H. The pathology of meconium ileus equivalent. J Clin Pathol 1983, 36:1292-1297. PMID:6630579, 10.1136/jcp.36.11.1292, 498548, 6630579.
7. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007, 44:212-218. PMID:17255834, 10.1097/MPG.0b013e31802c0ceb, 17255834.
8. Clarke LL, Gawenis LR, Bradford EM, Judd LM, Boyle KT, Simpson JE, Shull GE, Tanabe H, Ouellette AJ, Franklin CL, Walker NM. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1050-G1058. PMID:14715526, 10.1152/ajpgi.00393.2003, 14715526.
9. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1032-G1041. PMID:14739145, 10.1152/ajpgi.00473.2003, 14739145.
10. De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007, 293:G577-G584. PMID:17615175, 10.1152/ajpgi.00195.2007, 17615175.
11. King SJ, Button BM, Kelly MJ, Roberts SK, Nyulasi IB, Kotsimbos T, Wilson JW. Delayed gastric emptying is common in adults with cystic fibrosis and is associated with lower body mass index. Pediatr Pulmonol 2006, 29(Suppl):373. (abstract).
12. Schappi MG, Roulet M, Rochat T, Belli DC. Electrogastrography reveals postprandial gastric dysmotility in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2004, 39:253-256. PMID:15319624, 10.1097/00005176-200409000-00005, 15319624.
13. De Lisle RC, Meldi L, Flynn M, Jansson K. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr 2008, 47:406-416. PMID:18852632, 10.1097/MPG.0b013e31817e0f2c, 18852632.
14. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2006, 290:G942-G947. PMID:16603730, 10.1152/ajpgi.00264.2005, 16603730.
15. Sweetser S, Busciglio IA, Camilleri M, Bharucha AE, Szarka LA, Papathanasopoulos A, Burton DD, Eckert DJ, Zinsmeister AR. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009, 296:G295-G301. PMID:19033530, 10.1152/ajpgi.90558.2008, 2643920, 19033530.
16. Bennett HS, Rutland TJ, Di Palma JA. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study. Gastrointest Endosc 2009, PMID:19577749.
17. Joo NS, Wine JJ, Cuthbert AW. Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans. Am J Physiol Lung Cell Mol Physiol 2009, 296:L811-L824. PMID:19233902, 10.1152/ajplung.90636.2008, 2681353, 19233902.
18. O'Brien CE, Anderson PJ, Stowe CD. Use of the Chloride Channel Activator Lubiprostone for Constipation in Adults with Cystic Fibrosis: A Case Series (March). Ann Pharmacother 2010, 44:577-581. PMID:20179256, 10.1345/aph.1M642, 20179256.
19. Wood JD. Enteric nervous system: sensory physiology, diarrhea and constipation. Curr Opin Gastroenterol 2010, 26:102-108. PMID:19926984, 10.1097/MOG.0b013e328334df4f, 19926984.
20. Mizumori M, Akiba Y, Kaunitz JD. Lubiprostone stimulates duodenal bicarbonate secretion in rats. Dig Dis Sci 2009, 54:2063-2069. PMID:19657734, 10.1007/s10620-009-0907-0, 2737111, 19657734.
21. MacVinish LJ, Cope G, Ropenga A, Cuthbert AW. Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR. Br J Pharmacol 2007, 150:1055-1065. PMID:17339840, 10.1038/sj.bjp.0707175, 2013912, 17339840.
22. Cuppoletti J, Malinowska DH, Tewari KP, Li QJ, Sherry AM, Patchen ML, Ueno R. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol 2004, 287:C1173-C1183. PMID:15213059, 10.1152/ajpcell.00528.2003, 15213059.
23. Bijvelds MJ, Bot AG, Escher JC, De Jonge HR. Activation of intestinal Cl- secretion by lubiprostone requires the Cystic Fibrosis Transmembrane conductance Regulator. Gastroenterology 2009, PMID:19454284.
24. Fei G, Wang YZ, Liu S, Hu HZ, Wang GD, Qu MH, Wang XY, Xia Y, Sun X, Bohn LM, Cooke HJ, Wood JD. Stimulation of Mucosal Secretion by Lubiprostone (SPI-0211) in Guinea Pig Small Intestine and Colon. Am J Physiol Gastrointest Liver Physiol 2009, PMID:19179625, 2670663, 19179625.
25. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Edgar R. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009, 37:D885-D890. PMID:18940857, 10.1093/nar/gkn764, 2686538, 18940857.
26. Liu W, Saint DA. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 2002, 302:52-59. PMID:11846375, 10.1006/abio.2001.5530, 11846375.
27. Norkina O, De Lisle RC. Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10. BMC Genet 2005, 6:29. PMID:15921521, 10.1186/1471-2156-6-29, 1166548, 15921521.
28. De Lisle RC. Altered Transit and Bacterial Overgrowth in the Cystic Fibrosis Mouse Small Intestine. Am J Physiol Gastrointest Liver Physiol 2007, 293:G104-G111. PMID:17363465, 10.1152/ajpgi.00548.2006, 17363465.
29. De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLos ONE 2009, 4:e4283. PMID 19172182, 10.1371/journal.pone.0004283, 2627938, 19172182.
30. Merlin D, Guo XW, Martin K, Laboisse C, Landis D, Dubyak G, Hopfer U. Recruitment of purinergically stimulated Cl- channels from granule membrane to plasma membrane. Am J Physiol Cell Physiol 1996, 271:C612-C619. PMID: 8770002.
31. Garcia MAS, Yang N, Quinton PM. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009, 119:2613-2622. PMID:19726884, 10.1172/JCI38662, 2735925, 19726884.
32. Delavoie F, Molinari M, Milliot M, Zahm JM, Coraux C, Michel J, Balossier G. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells. Am J Respir Cell Mol Biol 2009, 40:388-397. PMID:18931328, 10.1165/rcmb.2008-0037OC, 18931328.
33. Bassil AK, Borman RA, Jarvie EM, rthur-Wilson RJ, Thangiah R, Sung EZ, Lee K, Sanger GJ. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol 2008, 154:126-135. PMID:18332851, 10.1038/bjp.2008.84, 2438971, 18332851.
34. Cuppoletti J, Malinowska DH, Chakrabarti J, Ueno R. Effects of lubiprostone on human uterine smooth muscle cells. Prostaglandins Other Lipid Mediat 2008, 86:56-60. PMID:18440264, 10.1016/j.prostaglandins.2008.03.001, 18440264.
35. Brown JK, Knight PA, Thornton EM, Pate JA, Coonrod S, Miller HR, Pemberton AD. Trichinella spiralis induces de novo expression of group IVC phospholipase A2 in the intestinal epithelium. Int J Parasitol 2008, 38:143-147. PMID:18001740, 10.1016/j.ijpara.2007.10.002, 18001740.
36. Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, Yanagihara K, Tamura M, Mizushima H, Sakamoto H, Ogawa K, Ohki M, Shiroishi T, Yoshida T, Sasaki H. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-betadependent apoptotic signalling. Oncogene 2007, 26:6488-6498. PMID:17471240, 10.1038/sj.onc.1210475, 17471240.
37. Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G839-G848. PMID:17095751, 10.1152/ajpgi.00582.2005, 17095751.
38. Sherry AM, Malinowska DH, Morris RE, Ciraolo GM, Cuppoletti J. Localization of ClC-2 Cl- channels in rabbit gastric mucosa. Am J Physiol Cell Physiol 2001, 280:C1599-C1606. PMID:11350755.
39. Bao HF, Liu L, Self J, Duke BJ, Ueno R, Eaton DC. A Synthetic Prostone Activates Apical Chloride Channels in A6 Epithelial Cells. Am J Physiol Gastrointest Liver Physiol 2008, 295:G234-251G. PMID:18511742, 10.1152/ajpgi.00366.2007, 2519861, 18511742.
40. Tuo B, Riederer B, Wang Z, Colledge WH, Soleimani M, Seidler U. Involvement of the anion exchanger SLC26A6 in prostaglandin E2- but not forskolin-stimulated duodenal. Gastroenterology 2006, 130:349-358. PMID:16472591, 10.1053/j.gastro.2005.10.017, 16472591.